Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
A completed clinical trial update analyzing adherence to antipsychotic medications in patients admitted for acute psychosis by measuring ser…
-
CLINICAL_TRIALS research · 2015-04-14Clinical Trial Update: Famotidine in Schizophrenia [Phase 2, Phase 3]
Clinical trial update on famotidine for schizophrenia, covering Phase 2 and Phase 3, with current status unknown.
-
FDA approval · 2015-04-13FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ziprasidone submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia [NA]
Clinical trial update reporting results for a mindfulness meditation rehabilitation strategy in individuals with schizophrenia and related p…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia [Phase 4]
A Phase 4 trial evaluated whether adding pimozide to clozapine improves outcomes in schizophrenia; results were posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia [Phase 4]
A Phase 4 trial comparing clozapine to olanzapine for treatment-resistant schizophrenia has completed, assessing relative effectiveness betw…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP) [NA]
This completed clinical trial evaluates the EQUIP collaborative care model for schizophrenia, including related schizoaffective disorder, wi…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Improving Health Services for Veterans With Schizophrenia
The US Department of Veterans Affairs completed a clinical trial evaluating improvements in health services for veterans with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia [Phase 4]
A Phase 4 randomized trial comparing clozapine to haloperidol for first-episode schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia [Phase 4]
A Phase 4 clinical trial comparing clozapine to chlorpromazine for treatment-unresponsive schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines [NA]
This completed multi-site study investigated strategies for implementing guidelines for schizophrenia care.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Psychiatric Advance Directives for Improved Mental Health Care [NA]
This update reports on a completed VA-sponsored clinical trial evaluating psychiatric advance directives to improve mental health care for i…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Improving Antipsychotic Adherence Among Patients With Serious Mental Illness [NA]
A completed clinical trial update focusing on improving adherence to antipsychotic therapy among people with serious mental illness.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: A Study of Strategies to Improve Schizophrenia Treatment [NA]
A completed clinical trial evaluating strategies to improve treatment for schizophrenia and schizoaffective disorder has finished.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Functional Rehabilitation of Older Patients With Schizophrenia [NA]
A completed clinical trial evaluated functional rehabilitation for older patients with schizophrenia and related psychotic disorders; result…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI [NA]
A completed clinical trial evaluating the effect of an atypical antipsychotic on brain function in schizophrenia as measured by functional M…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of oral aripiprazole in adolescents with schizophrenia has completed, with results…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Definitive Estrogen Patch Study (ADEPT) [Phase 2]
A phase 2 clinical trial (ADEPT) evaluating an estrogen patch for schizophrenia and related disorders has completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating augmentation with amisulpride in patients with schizophrenia unresponsive to clozapine; the study status i…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia [Phase 3]
An open-label extension study of aripiprazole intramuscular depot (OPC-14597, Lu AF41155) in patients with schizophrenia completed Phase 3 t…
-
FDA approval · 2015-03-30FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for FANAPT (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole [Phase 3]
Open-label Phase 3 trial comparing hospitalization rates in schizophrenia patients treated with oral antipsychotics versus intramuscular dep…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: L-arginine add-on Therapy in Patients With Schizophrenia [NA]
A clinical trial evaluating L-arginine as add-on therapy for schizophrenia and schizoaffective disorder has completed.
-
FDA approval · 2015-03-20FDA Approved: MOLINDONE HYDROCHLORIDE — Original Application (EPIC PHARMA, LLC)
FDA approved molindone hydrochloride as a generic drug through an Original Application by EPIC PHARMA, LLC.
-
FDA approval · 2015-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride by Apotex Corp., approving the generic product under the ANDA.